CORRESP Filing
Can-Fite BioPharma Ltd.
Date: July 24, 2025 · CIK: 0001536196 · Accession: 0001213900-25-067307
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288890
Letter
Can-Fite BioPharma Ltd.
26 Ben Gurion Street
Ramat Gan 5257346 Israel
July 24, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: Can-Fite BioPharma Ltd. (CIK 0001536196)
Registration Statement No. 333-288890 on Form F-1 (the "Registration Statement")
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 28, 2025 at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at +1 212 801 9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
Very truly yours,
Can-Fite BioPharma LTD.
Show Raw Text
CORRESP 1 filename1.htm Can-Fite BioPharma Ltd. 26 Ben Gurion Street Ramat Gan 5257346 Israel July 24, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 RE: Can-Fite BioPharma Ltd. (CIK 0001536196) Registration Statement No. 333-288890 on Form F-1 (the "Registration Statement") Ladies and Gentlemen: Can-Fite BioPharma Ltd. (the " Registrant ") hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), so that it may become effective on July 28, 2025 at 9:00 a.m., Eastern Time, or as soon thereafter as is practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at +1 212 801 9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, Can-Fite BioPharma LTD. By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer